Curtin University of Technology, Centre for Cardiovascular and Chronic Care, Curtin Health Innovation Research Institute, 39 Regent Street, Chippendale, New South Wales 2008, Australia.
Heart Lung Circ. 2010 May-Jun;19(5-6):372-7. doi: 10.1016/j.hlc.2010.01.010. Epub 2010 Mar 30.
Poor medication adherence is associated with adverse health outcomes. Improving access and adherence to pharmacological therapy is important in achieving optimal health outcomes for Indigenous populations. In spite of the impressive evidence base for cardiovascular pharmacotherapy, strategies for promoting adherence and evidence based practice are less well refined and the challenges for Indigenous populations are more pronounced.
To identify factors impacting on medication adherence in Aboriginal Australians and identify solutions to improve the quality use of medicines.
The World Health Organization adherence model was used to classify barriers to adherence. Key elements of this model are (1) health care team/health system; (2) socio-economic factors; (3) therapy; (4) patient; and (5) condition related.
Entrenched socio-economic differentials aggravate challenges to medication adherence amongst Aboriginal Australians. Initiatives to promote the quality use of medicines, such as the Quality Use of Medicines Maximised for Aboriginal and Torres Strait Islander People (QUMAX) Program, are important strategies to promote adherence.
Medication adherence is a complex issue and addressing modifiable factors is imperative to improve health outcomes. Subsidised access to medications whether living in urban, regional, rural or remote areas is an important strategy in Closing the Gap.
药物依从性差与不良健康结果相关。改善获得药物和药物治疗依从性对于实现原住民人群的最佳健康结果非常重要。尽管心血管药物治疗的证据令人印象深刻，但促进依从性和循证实践的策略还不够完善，原住民人群面临的挑战更加明显。
确定影响澳大利亚原住民药物依从性的因素，并确定改善药物合理使用质量的解决方案。
使用世界卫生组织依从性模型对依从性障碍进行分类。该模型的关键要素包括 (1) 医疗保健团队/卫生系统；(2) 社会经济因素；(3) 治疗；(4) 患者；和 (5) 与病情相关的因素。
根深蒂固的社会经济差异加剧了澳大利亚原住民在药物依从性方面的挑战。促进药物合理使用的举措，如针对原住民和托雷斯海峡岛民的优化药物使用质量计划 (QUMAX)，是促进依从性的重要策略。
药物依从性是一个复杂的问题，解决可改变的因素对于改善健康结果至关重要。无论是在城市、地区、农村还是偏远地区，药物补贴获取是缩小差距的重要策略。
